Alessandro Schuffner
Alessandro Schuffner has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Isadora Ferreira Kozlowski
Conceber Centro de Medicina Reprodutiva Curitiba Paraná Brazil
5 shared publicationsVinicius Bonato da Rosa
Brown Fertility - Florida Fertility Clinics, Jacksonville, Florida, United States
4 shared publicationsMatheus Campos Carneiro
3 shared publicationsCamila Dutra De Souza Francisquini
2 shared publicationsCamila Dutra de Souza Francisquini
Conceber Ctr Med Reprod, BR-80240210 Curitiba, PR, Brazil
2 shared publicationsGabriela Schuffner
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Fortune Journals in Journal of Radiology and Clinical Imaging
- Vol. 8 (4) , 135-145
Impact of Gonadotrophin Dose on Ovarian Stimulation for IVF and Embryo Ploidy: A Cohort Study
The relationship between gonadotropin dosage and embryo ploidy status in in vitro fertilization (IVF) remains controversial, with previous studies yielding conflicting results. While some evidence suggests that higher gonadotropin doses may increase aneuploidy rates due to meiotic disruption, other investigations have not confirmed this association. In this retrospective cohort study, we evaluated the impact of total gonadotropin dose administered during controlled ovarian stimulation on the number of euploid embryos obtained following preimplantation genetic testing for aneuploidies (PGT-A).A total of 245 patients were allocated into two groups according to gonadotropin dosage (≤3000 IU, n=150; >3000 IU, n=95). Patients in the lower-dose group exhibited a shorter stimulation period and a significantly higher number of follicles, oocytes, metaphase II oocytes, zygotes, blastocysts, and euploid blastocysts. Subgroup analysis according to stimulation protocol demonstrated superior outcomes in younger patients receiving recombinant FSH (rFSH) alone, including higher follicular counts, oocyte yield, and euploid embryo numbers. Furthermore, infertility diagnosis influenced the outcomes, with male factor and unexplained infertility groups achieving better embryological parameters compared to those with female factor or combined female and male factors. Notably, the unexplained infertility group yielded the highest number of euploid blastocysts, whereas the combined female plus male factor group demonstrated the lowest euploidy rates. A positive correlation was observed between embryo production and euploidy, while maternal age and higher gonadotropin doses correlated negatively with euploid outcomes. These findings suggest that lower gonadotropin doses, particularly within rFSH-only protocols, may enhance embryo chromosomal integrity and improve clinical outcomes in IVF.
- 1 January 2025
- Published by Fortune Journals in Journal of Radiology and Clinical Imaging
- Vol. 8 (4) , 135-145
Open AccessImpact of Gonadotrophin Dose on Ovarian Stimulation for IVF and Embryo Ploidy: A Cohort Study
The relationship between gonadotropin dosage and embryo ploidy status in in vitro fertilization (IVF) remains controversial, with previous studies yielding conflicting results. While some evidence suggests that higher gonadotropin doses may increase aneuploidy rates due to meiotic disruption, other investigations have not confirmed this association. In this retrospective cohort study, we evaluated the impact of total gonadotropin dose administered during controlled ovarian stimulation on the number of euploid embryos obtained following preimplantation genetic testing for aneuploidies (PGT-A).A total of 245 patients were allocated into two groups according to gonadotropin dosage (≤3000 IU, n=150; >3000 IU, n=95). Patients in the lower-dose group exhibited a shorter stimulation period and a significantly higher number of follicles, oocytes, metaphase II oocytes, zygotes, blastocysts, and euploid blastocysts. Subgroup analysis according to stimulation protocol demonstrated superior outcomes in younger patients receiving recombinant FSH (rFSH) alone, including higher follicular counts, oocyte yield, and euploid embryo numbers. Furthermore, infertility diagnosis influenced the outcomes, with male factor and unexplained infertility groups achieving better embryological parameters compared to those with female factor or combined female and male factors. Notably, the unexplained infertility group yielded the highest number of euploid blastocysts, whereas the combined female plus male factor group demonstrated the lowest euploidy rates. A positive correlation was observed between embryo production and euploidy, while maternal age and higher gonadotropin doses correlated negatively with euploid outcomes. These findings suggest that lower gonadotropin doses, particularly within rFSH-only protocols, may enhance embryo chromosomal integrity and improve clinical outcomes in IVF.
- Open Access
- 11 September 2024
- Published by Springer Nature in Research Square
Impact of Gonadotrophin Dose Used on Ovarian Stimulation for IVF on Embryo Ploidy Status
Purpose Does the amount of gonadotrophin used during an IVF cycle affect the the number of euploid embryos by patients of different ages? Methods A descriptive, retrospective, observational study with 245 patients divided in two experimental groups considering the total gonadotropin dose used (≤ 3000 IU n = 150 or > 3000 IU n = 45). Results Patients from group ≤ 3000 IU had a shorter stimulation period, higher number of follicles, oocytes and MII retrieved, zygotes, number of blastocysts and euploid blastocysts. Regarding the kind of protocol, patients in rFSH-only group were younger, with more follicles, total and MII retrieved oocytes, zygotes, number of blastocysts and euploid blastocysts. When evaluating infertility diagnosis, the number of follicles, total and MII retrieved oocytes and zygotes were greater in the male factor group and unexplained factor compared to female plus male and mainly with female factor group. Moreover, the number of euploid blastocysts was greater in the unexplained factor group, and the female plus male group showed the lowest euploidy. A positive correlation was found between IVF outcomes and euploidy. A negative correlation was observed between embryo euploidy and maternal age and gonadotropin dose. Conclusions Lower doses of gonadotropin are more likely to produce more euploid blastocysts when comparing to higher dose group. The use of rFSH is related to younger patients and more euploid embryos. When female factor is present there was lower euploidy. It was also observed a positive correlation between embryo production and euploidy.
- 11 September 2024
- Published by Springer Nature in Research Square
Open AccessImpact of Gonadotrophin Dose Used on Ovarian Stimulation for IVF on Embryo Ploidy Status
Purpose Does the amount of gonadotrophin used during an IVF cycle affect the the number of euploid embryos by patients of different ages? Methods A descriptive, retrospective, observational study with 245 patients divided in two experimental groups considering the total gonadotropin dose used (≤ 3000 IU n = 150 or > 3000 IU n = 45). Results Patients from group ≤ 3000 IU had a shorter stimulation period, higher number of follicles, oocytes and MII retrieved, zygotes, number of blastocysts and euploid blastocysts. Regarding the kind of protocol, patients in rFSH-only group were younger, with more follicles, total and MII retrieved oocytes, zygotes, number of blastocysts and euploid blastocysts. When evaluating infertility diagnosis, the number of follicles, total and MII retrieved oocytes and zygotes were greater in the male factor group and unexplained factor compared to female plus male and mainly with female factor group. Moreover, the number of euploid blastocysts was greater in the unexplained factor group, and the female plus male group showed the lowest euploidy. A positive correlation was found between IVF outcomes and euploidy. A negative correlation was observed between embryo euploidy and maternal age and gonadotropin dose. Conclusions Lower doses of gonadotropin are more likely to produce more euploid blastocysts when comparing to higher dose group. The use of rFSH is related to younger patients and more euploid embryos. When female factor is present there was lower euploidy. It was also observed a positive correlation between embryo production and euploidy.
- Open Access
- 1 January 2023
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 27 (4) , 629-637
Dual trigger and the impact on oocyte quality and embryo development: a Brazilian cohort
Objective: We aimed to analyze controlled ovarian stimulation using GnRH antagonist in association with triggering) for final oocyte maturation triggering in a population of unselected Brazilian women. Methods: This was a retrospective observational study of IVF medical records between January 2019 and March 2020. Data from 335 women with infertility were included for study. All patients were divided into hCG trigger (control group; n=178) and dual trigger (n=157).Results: The number of total oocytes and the number of inseminated oocytes were all significantly higher with the dual trigger protocol compared to hCG-only trigger. However, there is no significant difference in patient age, type of infertility, number of in vitro matured oocytes, trigger day, endometrial thickness, AMH concentration, the number of follicles, the number of mature oocytes and the number of fertilized oocytes.Conclusions: Using the dual trigger protocol improved the number of total oocytes retrieved and the number of inseminated oocytes.
- 1 January 2023
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 27 (4) , 629-637
Open AccessDual trigger and the impact on oocyte quality and embryo development: a Brazilian cohort
Objective: We aimed to analyze controlled ovarian stimulation using GnRH antagonist in association with triggering) for final oocyte maturation triggering in a population of unselected Brazilian women. Methods: This was a retrospective observational study of IVF medical records between January 2019 and March 2020. Data from 335 women with infertility were included for study. All patients were divided into hCG trigger (control group; n=178) and dual trigger (n=157).Results: The number of total oocytes and the number of inseminated oocytes were all significantly higher with the dual trigger protocol compared to hCG-only trigger. However, there is no significant difference in patient age, type of infertility, number of in vitro matured oocytes, trigger day, endometrial thickness, AMH concentration, the number of follicles, the number of mature oocytes and the number of fertilized oocytes.Conclusions: Using the dual trigger protocol improved the number of total oocytes retrieved and the number of inseminated oocytes.
- Open Access
- 1 January 2023
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 27 (4) , 594-601
Impact of Body Mass Index and advanced maternal age on in vitro fertilization outcomes
To evaluate the impact of body mass index associated with advanced maternal age on pregnancy outcomes. A retrospective and observational study that included 808 in vitro fertilization cycles and evaluated: age, weight, height, number of oocytes and mature oocytes, number of embryos and transferred embryos, fertilization and clinical pregnancy rates. Four categories of body mass index: underweight, adequate weight, overweight and obesity. We classified age into 4 categories: 35-37; 38-40; 41-42 and over 42 years of age. The means and rates were calculated and compared between different ages and body mass index groups. For the fresh group, women who achieved clinical pregnancy had a lower mean age than those who did not become pregnant, being the higher the pregnancy rate the lower the age (p<0.0001). After logistic regression analysis for data associated with clinical pregnancy in the fresh group, the number of transferred embryos remained higher in the overweight category (p=0.0001). Overweight and obese women had a significantly higher rate of mature oocytes when compared with adequate weight (p=0.015). Analysis using the ROC curve indicated an area under the curve of 60% (p=0.002) for the fresh group. The adverse effect of high BMI on clinical pregnancy rates is greater in women under 35 years compared to older women; and age had a higher impact on live birth rate rather than BMI, when the analysis was performed on older women, with the impact of BMI on the probability of having a live birth depending on maternal age.
- 1 January 2023
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 27 (4) , 594-601
Open AccessImpact of Body Mass Index and advanced maternal age on in vitro fertilization outcomes
To evaluate the impact of body mass index associated with advanced maternal age on pregnancy outcomes. A retrospective and observational study that included 808 in vitro fertilization cycles and evaluated: age, weight, height, number of oocytes and mature oocytes, number of embryos and transferred embryos, fertilization and clinical pregnancy rates. Four categories of body mass index: underweight, adequate weight, overweight and obesity. We classified age into 4 categories: 35-37; 38-40; 41-42 and over 42 years of age. The means and rates were calculated and compared between different ages and body mass index groups. For the fresh group, women who achieved clinical pregnancy had a lower mean age than those who did not become pregnant, being the higher the pregnancy rate the lower the age (p<0.0001). After logistic regression analysis for data associated with clinical pregnancy in the fresh group, the number of transferred embryos remained higher in the overweight category (p=0.0001). Overweight and obese women had a significantly higher rate of mature oocytes when compared with adequate weight (p=0.015). Analysis using the ROC curve indicated an area under the curve of 60% (p=0.002) for the fresh group. The adverse effect of high BMI on clinical pregnancy rates is greater in women under 35 years compared to older women; and age had a higher impact on live birth rate rather than BMI, when the analysis was performed on older women, with the impact of BMI on the probability of having a live birth depending on maternal age.
- 23 January 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 305 (6) , 1595-1604
Impact of assisted reproduction treatment on sexual function of patients diagnosed with infertility
Purpose This study aims to update and systematize the existing evidence on the prevalence of sexual dysfunction and depression in infertile couple Renatos undergoing assisted reproduction treatments. Methods A bibliographic search regarding sexual dysfunction in infertile couples was performed on PubMed and LILACS, with no restrictions on the date of publication of the article. The Newcastle–Ottawa Scale (NOS) was used to evaluate studies quality. Data collection process was conducted using a form previously planned and tested, extracting the goal information in a descriptive way. Results From 111 records, only eight prospective studies were included in the synthesis. Although most of the selected studies assessed only women, three studies assessed the couple. All of them used questionnaires that showed that infertile couples experienced a higher number of sexual dysfunctions during the infertility treatment process, especially women. Regarding depression, going through the infertility process and its treatment leads to significant emotional damage to the patient or couple. Conclusion Of the eight studies analyzed, six reached the conclusion that infertility is related to higher rates of sexual dysfunction. Seven studies also concluded that anxiety and depression are more prevalent in infertile patients. The treatment of sexual dysfunction is multidisciplinary, with the team being a general practitioner, gynecologist, psychologist and specialized nurse. If an organic disorder is detected, there may be a need to include specialists such as urology, gastroenterology and anesthesia. Psychological approaches often include some combination of sex education, identification of emotional and cultural factors, and eventually, couples therapy.
- 23 January 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 305 (6) , 1595-1604
Impact of assisted reproduction treatment on sexual function of patients diagnosed with infertility
Purpose This study aims to update and systematize the existing evidence on the prevalence of sexual dysfunction and depression in infertile couple Renatos undergoing assisted reproduction treatments. Methods A bibliographic search regarding sexual dysfunction in infertile couples was performed on PubMed and LILACS, with no restrictions on the date of publication of the article. The Newcastle–Ottawa Scale (NOS) was used to evaluate studies quality. Data collection process was conducted using a form previously planned and tested, extracting the goal information in a descriptive way. Results From 111 records, only eight prospective studies were included in the synthesis. Although most of the selected studies assessed only women, three studies assessed the couple. All of them used questionnaires that showed that infertile couples experienced a higher number of sexual dysfunctions during the infertility treatment process, especially women. Regarding depression, going through the infertility process and its treatment leads to significant emotional damage to the patient or couple. Conclusion Of the eight studies analyzed, six reached the conclusion that infertility is related to higher rates of sexual dysfunction. Seven studies also concluded that anxiety and depression are more prevalent in infertile patients. The treatment of sexual dysfunction is multidisciplinary, with the team being a general practitioner, gynecologist, psychologist and specialized nurse. If an organic disorder is detected, there may be a need to include specialists such as urology, gastroenterology and anesthesia. Psychological approaches often include some combination of sex education, identification of emotional and cultural factors, and eventually, couples therapy.
- 1 October 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 25 (4) , 647-649
Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of COVID-19, more than 85 million cases have been confirmed and most patients have sustained symptoms after more than six months of acute infection. This paper reports the case of a 38-year-old woman without signs of endometriosis and a history of COVID-19 infection who developed spontaneous hemothorax after oocyte retrieval. Three months before undergoing assisted reproductive technology (ART) treatment, the patient had a symptomatic COVID-19 infection with a negative PCR test and a positive IgG test four weeks after the onset of symptoms. Controlled ovarian stimulation and oocyte retrieval were conducted uneventfully. Two hours after oocyte retrieval, the patient developed nausea and mild hypogastric pain. Ten hours after the procedure, the patient went to the emergency department with abdominal pain. Chest computed tomography scans revealed moderate right pleural effusion and laminar left pleural effusion. Since the patient had respiratory symptoms, the choice was made to drain the pleural fluid. Fluid analysis confirmed the patient had right hemothorax (400 mL). After drainage, the patient's clinical and imaging signs improved gradually without complications. The patient was asymptomatic one week after the procedure.
- 1 October 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 25 (4) , 647-649
Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of COVID-19, more than 85 million cases have been confirmed and most patients have sustained symptoms after more than six months of acute infection. This paper reports the case of a 38-year-old woman without signs of endometriosis and a history of COVID-19 infection who developed spontaneous hemothorax after oocyte retrieval. Three months before undergoing assisted reproductive technology (ART) treatment, the patient had a symptomatic COVID-19 infection with a negative PCR test and a positive IgG test four weeks after the onset of symptoms. Controlled ovarian stimulation and oocyte retrieval were conducted uneventfully. Two hours after oocyte retrieval, the patient developed nausea and mild hypogastric pain. Ten hours after the procedure, the patient went to the emergency department with abdominal pain. Chest computed tomography scans revealed moderate right pleural effusion and laminar left pleural effusion. Since the patient had respiratory symptoms, the choice was made to drain the pleural fluid. Fluid analysis confirmed the patient had right hemothorax (400 mL). After drainage, the patient's clinical and imaging signs improved gradually without complications. The patient was asymptomatic one week after the procedure.
- Open Access
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 26 (2) , 214-221
Correlation between anti-Mu¨llerian hormone, age, and number of oocytes: A retrospective study in a Brazilian in vitro fertilization center
Objective: Is the AMH level correlated with age and number of mature oocytes retrieved from stimulated cycles? Methods: This descriptive, retrospective, observational study included the data of about 1500 patients submitted to Assisted Reproductive Technology treatments in a clinic in Brazil between July 2012 and April 2019. Patients not submitted to IVF and/or without AMH level records were excluded. The study included women with fertility issues aged 20-50 years submitted to IVF. A total of 733 patients were included. The patients were divided by age into three groups (<= 35 years old; 36-39 years old; >= 40 years old). Results: The mean AMH concentration ranged from 2.65 to 1.35 ng/mL and was significantly different between the groups. The mean total number of retrieved oocytes ranged from 9.5 to 5.42 and was significantly different between the groups. The mean number of mature oocytes ranged from 7.14 to 4.58. There was no significant difference in the number of mature oocytes between patients aged 36-39 years and >= 40 years. Negative correlations were observed between patient age and total number of retrieved oocytes (-0.3354) and number of mature oocytes (-0.2839). AMH was negatively correlated with age (-0.3257), although positive correlations with total number of oocytes (0.6702) and number of mature oocytes (0.5770) were observed. Conclusions: This is the largest study performed with Brazilian patients to correlate AMH levels, age, number of oocytes, and number of mature oocytes from controlled ovarian stimulation cycles. Our data showed that as age increases, AMH levels, number of retrieved oocytes, and number of mature oocytes decrease significantly. However, no significant difference in number of mature oocytes was observed when patients aged 36-39 and >= 40 years were compared. In addition, a positive correlation was found between serum AMH levels and total number of retrieved and mature oocytes from stimulated cycles.
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 26 (2) , 214-221
Open AccessCorrelation between anti-Mu¨llerian hormone, age, and number of oocytes: A retrospective study in a Brazilian in vitro fertilization center
Objective: Is the AMH level correlated with age and number of mature oocytes retrieved from stimulated cycles? Methods: This descriptive, retrospective, observational study included the data of about 1500 patients submitted to Assisted Reproductive Technology treatments in a clinic in Brazil between July 2012 and April 2019. Patients not submitted to IVF and/or without AMH level records were excluded. The study included women with fertility issues aged 20-50 years submitted to IVF. A total of 733 patients were included. The patients were divided by age into three groups (<= 35 years old; 36-39 years old; >= 40 years old). Results: The mean AMH concentration ranged from 2.65 to 1.35 ng/mL and was significantly different between the groups. The mean total number of retrieved oocytes ranged from 9.5 to 5.42 and was significantly different between the groups. The mean number of mature oocytes ranged from 7.14 to 4.58. There was no significant difference in the number of mature oocytes between patients aged 36-39 years and >= 40 years. Negative correlations were observed between patient age and total number of retrieved oocytes (-0.3354) and number of mature oocytes (-0.2839). AMH was negatively correlated with age (-0.3257), although positive correlations with total number of oocytes (0.6702) and number of mature oocytes (0.5770) were observed. Conclusions: This is the largest study performed with Brazilian patients to correlate AMH levels, age, number of oocytes, and number of mature oocytes from controlled ovarian stimulation cycles. Our data showed that as age increases, AMH levels, number of retrieved oocytes, and number of mature oocytes decrease significantly. However, no significant difference in number of mature oocytes was observed when patients aged 36-39 and >= 40 years were compared. In addition, a positive correlation was found between serum AMH levels and total number of retrieved and mature oocytes from stimulated cycles.